Mirashrafi Fatemeh, Tavakolnejad Fatemeh, Amirzargar Behrooz, Abasi Arezou, Amali Amin
Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Otorhinolaryngol. 2021 Nov;33(119):355-359. doi: 10.22038/IJORL.2021.56501.2945.
The present study aimed to compare the effects of paracetamol and ibuprofen on pain, bleeding, nausea, and vomiting following adenotonsillectomy in children.
This was a prospective, double-blinded, randomized clinical trial. Block randomization was used to assign 50 patients to two groups of paracetamol and ibuprofen. In the paracetamol group, subjects received 15 mg/kg oral paracetamol 30 minutes before the induction of anesthesia, followed by the same dosage every 6 hours postoperatively. Meanwhile, the ibuprofen-treated group took 10 mg/kg oral ibuprofen 30 minutes before and every 6 hours after the operation. The subjects in both groups received the medication for three postoperative days. The postoperative pain score was assessed 6 hours after the surgery and during the second and the third postoperative days. Nausea and vomiting episodes were recorded in the first postoperative day and first postoperative week.
Based on the results, intraoperative and postoperative bleeding in both groups was not significantly different. The mean score of pain in the first postoperative day (6 hours after the surgery) and the second and the third postoperative days did not show any statistical difference. The ibuprofen group experienced fewer vomiting episodes, compared to the paracetamol group during the first postoperative day (P=0.011). Vomiting episodes in the first postoperative week did not illustrate any significant difference.
As evidenced by the results of the current study, Ibuprofen had the same effect on the alleviation of postoperative pain, caused fewer vomiting episodes, and did not cause excessive bleeding as an NSAID. Therefore, oral administration of ibuprofen is suggested for pain relief and management of other complications following adenotonsillectomy in children.
本研究旨在比较对乙酰氨基酚和布洛芬对儿童腺样体扁桃体切除术后疼痛、出血、恶心和呕吐的影响。
这是一项前瞻性、双盲、随机临床试验。采用区组随机化将50例患者分为对乙酰氨基酚组和布洛芬组。在对乙酰氨基酚组,受试者在麻醉诱导前30分钟口服15mg/kg对乙酰氨基酚,术后每6小时服用相同剂量。同时,布洛芬治疗组在手术前30分钟和术后每6小时口服10mg/kg布洛芬。两组受试者术后连续三天服用该药物。术后6小时以及术后第二天和第三天评估术后疼痛评分。记录术后第一天和术后第一周的恶心和呕吐发作情况。
结果显示,两组术中及术后出血无显著差异。术后第一天(术后6小时)以及术后第二天和第三天的平均疼痛评分无统计学差异。与对乙酰氨基酚组相比,布洛芬组在术后第一天呕吐发作较少(P=0.011)。术后第一周的呕吐发作无显著差异。
本研究结果表明,布洛芬在缓解术后疼痛方面效果相同,呕吐发作较少,且作为非甾体抗炎药不会引起过多出血。因此,建议口服布洛芬用于儿童腺样体扁桃体切除术后的疼痛缓解和其他并发症的处理。